Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers at Oxford University have received a prestigious Wellcome Innovator Grant for investigating the role of the pedunculopontine nucleus (PPN) – a brainstem nucleus – in human consciousness.

Human brain

The study is a collaboration between Neurosurgery (Associate Professor Alex Green, Nuffield Department of Surgical Sciences), Engineering (Professor Tim Denison, MRC Brain Network Dynamics Unit), and Neurology (Dr Damian Jenkins, Nuffield Department of Clinical Neurosciences). It builds on pilot data from Dr Alceste Deli who, during her DPhil, has shown that PPN stimulation can alter sleep and arousal states.

The project will involve a 10-subject first-in-man clinical trial of PPN stimulation in patients with minimally conscious state (MCS) following brain injury (trauma or stroke) and will involve further development of a Deep Brain Stimulation system called the ‘DyNeuMo’ that has been developed in Oxford by Professor Denison and his team.

The research team aim to identify biomarkers that signify arousal state, within the brain and on EEG, and to develop ‘closed-loop’ stimulation patterns that optimise increased arousal and improve sleep. The device will also take into account circadian rhythms that are often disrupted in patients with MCS.

Read the full story on the Nuffield Department of Surgical Sciences website

Similar stories

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.